Posts by Raymond J. March
Raymond J. March is a Research Fellow and Director of FDAReview.org with the Independent Institute. He is also an Assistant Professor of Economics at Angelo State University where he is the Assistant Director of the Free Market Institute, Assistant Research Professor at Texas Tech University, Public Choice and Public Policy fellow with the American Institute for Economic Research, and an affiliated scholar with the Challey Institute for Global Innovation and Growth. His research has appeared in Health Economics, Southern Economic Journal, Public Choice, Research Policy, Food Policy, Journal of Institutional Economics, The Independent Review and other academic outlets. His popular articles have appeared in Fortune, Washington Examiner, National Interest, Washington Times, Sun Sentinel, The Hill, Real Clear Health, Medical News Daily. He earned his Ph.D. from Texas Tech University.
Right-to-Try Laws Help Patient with Terminal Brain Cancer
FDA Approves Record Number of Generic Drugs in 2018
Teen Vaping Is Bad, but the Alternative Is Worse
Can the FDA Prevent Teens from Vaping?
Deregulation Is the Only Cure for High Drug Prices
FDA Vaping Regulations Will Do More Harm than Good
To Help the Terminally Ill, the FDA Must Deregulate
When Healthy Policy Neglects Economic Principles, Patients Suffer
FDA Still Hooked on Meddling in Nicotine Markets
FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple Syrup
Let Competition, Not the FDA, Resolve the EpiPen Shortage
Government vs. Private Efforts to Promote Breastfeeding: My Response to a Critic
FDA Considers Regulating E-cigarette Juices
FDA Approves Medical App for Contraception
Open Up Off-Label Drug Communication and Let the Market Work!
Three Reasons To Be Optimistic about Pharmaceutical Policy
If Telemedicine Is Underachieving, Government Is to Blame
Putting Right-to-Try Drug Prices in Perspective
EpiPen Pricing Controversy Reveals Ignorance about Market Competition
Dear Congress, Please Don’t Keep Up with the Kardashians!
FDA Moves Closer to Approving Ecstasy
Right-to-Try Law Signed!
Curing Diseases Is Sustainable, Government in Healthcare Is Not
FDA Issues First Mandatory Recall for Contaminated Food
FDA Restricts Sale of Contraceptive Device

  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org